New York Life Investment Management’s Autoliv ALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$955K Buy
8,222
+128
+2% +$15.2K 0.01% 697
2026
Q1
$851K Buy
8,094
+2,006
+33% +$237K 0.01% 700
2025
Q4
$723K Sell
6,088
-845
-12% -$101K 0.01% 672
2025
Q3
$856K Sell
6,933
-234
-3% -$28K 0.01% 688
2025
Q2
$802K Sell
7,167
-292
-4% -$28.6K 0.01% 682
2025
Q1
$660K Buy
7,459
+70
+0.9% +$6.67K 0.01% 729
2024
Q4
$693K Sell
7,389
-1,062
-13% -$102K 0.01% 740
2024
Q3
$789K Sell
8,451
-484
-5% -$48.2K 0.01% 741
2024
Q2
$956K Buy
8,935
+1,227
+16% +$146K 0.01% 696
2024
Q1
$928K Sell
7,708
-330
-4% -$36.9K 0.01% 692
2023
Q4
$886K Sell
8,038
-113
-1% -$11.3K 0.01% 687
2023
Q3
$786K Buy
8,151
+3,867
+90% +$370K 0.01% 678
2023
Q2
$364K Buy
+4,284
New +$371K ﹤0.01% 1125

Other funds holding ALV

New York Life Investment Management's ALV Position: Q2 2026 in Review

New York Life Investment Management increased its Autoliv (ALV) stake by 1.6% in Q2 2026, buying an estimated $15.2K and bringing the position to 8,222 shares worth $955K. The position accounts for 0.01% of the portfolio, ranked #697.

New York Life Investment Management first reported a position in ALV in Q2 2023 and has held it in 13 quarters since. The position peaked at $956K in Q2 2024. 297 funds tracked by Wall St. Rank hold ALV as of Q2 2026.

  • New York Life Investment Management held 8,222 shares of Autoliv worth $955K as of Q2 2026.
  • New York Life Investment Management bought 128 Autoliv shares in Q2 2026, an estimated $15.2K.
  • Autoliv made up 0.01% of New York Life Investment Management's portfolio in Q2 2026, its #697 holding.
  • New York Life Investment Management first reported a position in Autoliv in Q2 2023 and has held it in 13 quarters since.
  • New York Life Investment Management's Autoliv position peaked at $956K in Q2 2024.
  • 297 funds tracked by Wall St. Rank held Autoliv as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.